Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis Medicament

NCT01002170 · clinicaltrials.gov ↗

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Tuberculosis

Sponsor

Taipei Medical University WanFang Hospital

Collaborators

[object Object]